The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Addition of apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study.
 
Peter Schmid
No Relationships to Disclose
 
Dakshinmoorthy Muthukumar
No Relationships to Disclose
 
Fiona Helen Blackhall
No Relationships to Disclose
 
Jason Francis Lester
No Relationships to Disclose
 
Sarah Khan
No Relationships to Disclose
 
Marianne Illsley
No Relationships to Disclose
 
Joss Adams
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pierre Fabre
 
Angel Garcia-Alonso
No Relationships to Disclose
 
Carey MacDonald-Smith
No Relationships to Disclose
 
Siow Ming Lee
No Relationships to Disclose
 
Cindy Jacobs
Employment - Oncogenex
Leadership - Oncogenex
Stock and Other Ownership Interests - Oncogenex
Travel, Accommodations, Expenses - Oncogenex; Teva
 
Gary William Middleton
Honoraria - Merck Serono; Pierre Fabre; Roche Pharma AG
Research Funding - GemVax & KAEL
Travel, Accommodations, Expenses - MSD
 
Christine James
No Relationships to Disclose
 
Kelly Mousa
No Relationships to Disclose
 
Shah-Jalal Sarker
No Relationships to Disclose
 
Louise Lim
No Relationships to Disclose